Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
 Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
 Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
 Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
 Stroke Trial Links
Government Sites
Independent Sites
 News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback

 Search for Trials

PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit.



Principal Investigator
Geert Sulter, M.D.

PI Address
Department of Neurology
Academisch Ziekenhuis Groningen
Hanzeplein 1, 9713 GZ Groningen
Netherlands

Contact Email
g.a.sulter@neuro.azg.nl

Sponsor



Trial Phase:Phase I
Study Size Actual:54
Centers Actual:1
Max Time from onset:24 Hours
Max Age:80
Min Age:18
Follow-up Duration:3 Months
Status:
Trial complete. Results published March of 2003.

Purpose:
To examine whether intensive monitoring of acute stroke patients further reduces poor outcome and mortality of patients admited to organized stroke care units.

Interventions:
Stroke Units

Location(s):
The Netherlands.

Year Started: 2001
Year Finished: 2002
Year Published: 2003


Design:
Patients were stratified for stroke subtype and randomly assigned to either the stroke-care monitoring unit or a conventional stroke unit.

Inclusion Criteria
Patients with acute ischemic stroke in the carotid artery were eligible if they were between 18 and 80 years old, concious, symptoms started within 24 hours of admission, they were ineligible for intravenous thrombolysis and there was hemiparesis, with the affected outstretched arm unable to hold a 90 degree position for 10 seconds.

Exclusion Criteria
Patients were not included if they had had a previous stroke with residual neurological impairment, had any previous disorder interfering with neurological or functional assessments, had a life-threatening concurrent illness or had been previously treated with intravenous tissue-type plasminogen activator.

Patient Involvement:
Patients were randomized into a stroke-care monitoring unit (SCMU) or a conventional stroke unit (SU). All patients were treated in a similar way and strategies to treat complications were identical in both groups. SCMU patients were monitored continuously for 48 hours and moved to a conventional SU for further treatment.

Primary Outcome:
Poor outcome with a modified Rankin scale score greater than or equal to 4 or a Barthel Index less than 60, need for institutional care due to stroke, or mortality.

Results:
There was a statistically significant reduction in mortality (P=.05) for patients admitted to the SCMU and suggests acute ischemic stroke patients admitted to an SCMU may reduce mortality and poor outcome.

Source of Information:
Stroke. 2003;34:101-104

Web Links and Publications:
Admitting Acute Ischemic Stroke Patients to a Stroke Care Monitoring Unit Versus a Conventional Stroke Unit A Randomized Pilot Study
Stroke

This information last updated on: 7/16/2008

Reviewed on: 10/19/2009.

UID: 290

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009